Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Crysandt · SciRah

Researcher profile · Semantic Scholar

M. Crysandt

Share profile

M. Crysandt — researcher profile on SciRah

h-index: 21
Works: 164
Citations: 1,988

Most-cited papers

Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3-Internal Tandem Duplication Mutation (SORMAIN).
A. Burchert, G. Bug, Lea Fritz, J. Finke +37 more
2020Journal of Clinical Oncology468 citations Open access
Semantic Scholar
Heterogeneous bone-marrow stromal progenitors drive myelofibrosis via a druggable alarmin axis
N. Leimkühler, Hélène F. E. Gleitz, Ronghui Li, I. Snoeren +21 more
2020Cell Stem Cell160 citations Open access
Semantic Scholar
Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations
J. Eckardt, F. Stölzel, Desiree Kunadt, C. Röllig +37 more
2022Journal of Hematology & Oncology60 citations Open access
Semantic Scholar
Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents—a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group
E. Schuler, E. Wagner-Drouet, Salem Ajib, G. Bug +21 more
2020Annals of Hematology52 citations Open access
Semantic Scholar
EZH2 mutations and impact on clinical outcome: an analysis in 1,604 patients with newly diagnosed acute myeloid leukemia
S. Stasik, J. Middeke, M. Kramer, C. Röllig +32 more
2020Haematologica41 citations Open access
Semantic Scholar
Secondary-type mutations do not impact outcome in NPM1-mutated acute myeloid leukemia – implications for the European LeukemiaNet risk classification
J. Eckardt, Marius Bill, Christian Rausch, K. Metzeler +36 more
2023Leukemia38 citations Open access
Semantic Scholar
Alterations of cohesin complex genes in acute myeloid leukemia: differential co-mutations, clinical presentation and impact on outcome
J. Eckardt, S. Stasik, C. Röllig, T. Sauer +33 more
2023Blood Cancer Journal34 citations Open access
Semantic Scholar
Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia.
S. Stasik, J. Eckardt, M. Kramer, C. Röllig +33 more
2021Blood Advances31 citations Open access
Semantic Scholar
10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial.
M. Lübbert, P. Wijermans, M. Kicinski, S. Chantepie +32 more
2023The Lancet Haematology29 citations Open access
Semantic Scholar
Application of wearables for remote monitoring of oncology patients: A scoping review
Katharina Cloß, M. Verket, D. Müller-Wieland, Nikolaus Marx +8 more
2024Digital Health27 citations Open access
Semantic Scholar
Efficacy of Pazopanib With or Without Gemcitabine in Patients With Anthracycline- and/or Ifosfamide-Refractory Soft Tissue Sarcoma: Final Results of the PAPAGEMO Phase 2 Randomized Clinical Trial.
H. Schmoll, L. Lindner, P. Reichardt, K. Heissner +15 more
2020JAMA Oncology25 citations Open access
Semantic Scholar
Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study
S. Isfort, Kirsi Manz, Lino L. Teichmann, M. Crysandt +22 more
2023Annals of Hematology18 citations Open access
Semantic Scholar
Characteristics of infections after BCMA-directed CAR T-cell therapy for multiple myeloma: a real-world analysis
T. Richardson, D. Schütte, Guido Kobbe, Ben-Niklas Baermann +9 more
2025Blood Advances16 citations Open access
Semantic Scholar
Decitabine in Older Patients with AML: Quality of Life Results of the EORTC-GIMEMA-GMDS-SG Randomized Phase III Trial.
F. Efficace, M. Kicinski, C. Coens, S. Suciu +24 more
2024Blood16 citations Open access
Semantic Scholar
Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia
J. Eckardt, S. Stasik, C. Röllig, A. Petzold +34 more
2023Leukemia15 citations Open access
Semantic Scholar
A phase I first-in-man study to investigate the pharmacokinetics and safety of liposomal dexamethasone in patients with progressive multiple myeloma
J. Metselaar, T. Lammers, A. Boquoi, R. Fenk +6 more
2023Drug Delivery and Translational Research13 citations Open access
Semantic Scholar
Efficacy of Ropeginterferon Alpha 2b in Inducing Treatment Free Remission in Chronic Myeloid Leukemia - an International, Randomized Phase III Trial (ENDURE, CML-IX) of the German CML-Study Group
A. Burchert, S. Saussele, Christian Michel, S. Metzelder +30 more
2022Blood13 citations Open access
Semantic Scholar
Differential prognostic impact of myelodysplasia-related gene mutations in a European cohort of 4978 intensively treated AML patients
Marius Bill, J. Eckardt, K. Döhner, Maximillian-Alexander Röhnert +53 more
2025Leukemia12 citations Open access
Semantic Scholar
Loss-of-Function Mutations of BCOR Are an Independent Marker of Adverse Outcomes in Intensively Treated Patients with Acute Myeloid Leukemia
J. Eckardt, S. Stasik, M. Kramer, C. Röllig +35 more
2021Cancers12 citations Open access
Semantic Scholar
Therapeutic inhibition of FcγRIIb signaling targets leukemic stem cells in chronic myeloid leukemia
Oliver Parting, S. Langer, Maja Kim Kuepper, C. Wessling +10 more
2020Leukemia12 citations Open access
Semantic Scholar
Gemtuzumab ozogamicin in first-line treatment of CBF-AML: insights from a retrospective multi-center analysis
Julian Ronnacker, Philippe J. Muller, J. Mikesch, Sven Zukunft +50 more
2025Leukemia11 citations Open access
Semantic Scholar
S156: FRONTLINE ASCIMINIB COMBINATION IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS. THE FASCINATION TRIAL.
T. Ernst, P. le Coutre, M. Crysandt, T. Brümmendorf +13 more
2023HemaSphere10 citations Open access
Semantic Scholar
Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera: futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study group
S. Koschmieder, S. Isfort, D. Wolf, F. Heidel +19 more
2022Annals of Hematology10 citations Open access
Semantic Scholar
Targeting cytokine-induced leukemic stem cell persistence in chronic myeloid leukemia by IKK2-inhibition
Marlena Bütow, Fabio J Testaquadra, Julian Baumeister, Tiago Maié +7 more
2022Haematologica10 citations Open access
Semantic Scholar
Circular Anchors for the Detection of Hematopoietic Cells Using Retinanet
Philipp Gräbel, O. Ozkan, M. Crysandt, Reinhild Herwartz +5 more
2020IEEE International Symposium on Biomedical Imaging10 citations
Semantic Scholar
Domain-incremental white blood cell classification with privacy-aware continual learning
Pratibha Kumari, Afshin Bozorgpour, Daniel Reisenbüchler, Edgar Jost +3 more
2025Scientific Reports8 citations Open access
Semantic Scholar
The Combination of Asciminib with ATP Competing Tyrosine Kinase Inhibitors Might Overcome the Negative Impact of ASXL1 Mutations on Molecular Response in Newly Diagnosed CML Patients
T. Ernst, J. Rinke, P. le Coutre, M. Crysandt +8 more
2024Blood7 citations
Semantic Scholar
Impact of TP53 Mutation Status in Elderly AML Patients When Adding All‐Trans Retinoic Acid or Valproic Acid to Decitabine
H. Bresser, C. Schmoor, O. Grishina, Dietmar Pfeifer +30 more
2024European Journal of Haematology7 citations Open access
Semantic Scholar
Myelofibrosis at diagnosis is associated with the failure of treatment-free remission in CML patients
H. Jacobi, M. Vieri, Marlena Bütow, C. Y. Namasu +11 more
2023Frontiers in Pharmacology7 citations Open access
Semantic Scholar
Impact of BMI on patient outcome in acute myeloid leukaemia patients receiving intensive induction therapy: a real-world registry experience
Julius C. Enßle, S. Wolf, Sebastian Scheich, Sarah Weber +29 more
2023British Journal of Cancer7 citations Open access
Semantic Scholar
Randomized phase 3 trial of Ropeginterferon alfa-2b versus surveillance after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia (ENDURE/CML-IX)
A. Burchert, F. Nicolini, P. le Coutre, S. Saussele +49 more
2026Leukemia6 citations Open access
Semantic Scholar
Selective ABO immunoadsorption in hematopoietic stem cell transplantation with major ABO incompatibility
M. Crysandt, Hatice Soysal, Eva Jennes, U. Holtick +11 more
2021European Journal of Haematology6 citations Open access
Semantic Scholar
Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4
S. Kayser, D. Martínez-Cuadrón, M. Hanoun, F. Stölzel +43 more
2021Haematologica6 citations Open access
Semantic Scholar
State of the Art Cell Detection in Bone Marrow Whole Slide Images
Philipp Gräbel, O. Ozkan, M. Crysandt, Reinhild Herwartz +5 more
2021Journal of Pathology Informatics6 citations Open access
Semantic Scholar
VINCENT: A randomized-controlled trial evaluating venetoclax plus azacitidine versus intensive chemotherapy in patients with newly diagnosed, NPM1-mutated AML
Lydia Kretschmer, L. Ruhnke, C. Schliemann, L. Fransecky +37 more
2025Annals of Hematology5 citations Open access
Semantic Scholar
Improved long-term tolerability and efficacy of asciminib-based combination therapies in newly diagnosed CML patients - the fascination trial.
T. Ernst, P. le Coutre, M. Crysandt, G. Franke +14 more
2025Blood5 citations
Semantic Scholar
Insight into the mechanism of AML del(9q) progression: hnRNP K targets the myeloid master regulators CEBPA (C/EBPα) and SPI1 (PU.1).
K. Rahn, A. Abdallah, Lin Gan, Shelley Herbrich +13 more
2023Biochimica et Biophysica Acta. Gene Regulatory Mechanisms5 citations Open access
Semantic Scholar
Safety and Tolerability of AZD0466 As Monotherapy for Patients with Advanced Hematologic Malignancies. Results from a Phase I/II Trial
Shukaib Arslan, G. Marconi, G. Martinelli, Shaun A. Fleming +22 more
2023Blood5 citations Open access
Semantic Scholar
A post hoc analysis of the EPAZ trial: The role of geriatric variables in elderly soft tissue sarcoma patients on toxicity and outcome.
R. Hamacher, Xiao-feng Liu, M. Schuler, L. Hentschel +14 more
2022European Journal of Cancer5 citations
Semantic Scholar
Step-in Dosing in the Bosutinib Dose Optimization Study (BODO) Failed to Reduce Gastrointestinal (GI) Toxicity in Patients Failing Second Generation TKI (2G-TKI) in Chronic Phase Chronic Myeloid Leukemia (CML) but Suggests Promising Molecular Response
S. Isfort, D. Wolf, Lino L. Teichmann, M. Crysandt +13 more
2021Blood5 citations Open access
Semantic Scholar
Tolerability of high dose chemotherapy and autologous stem cell transplantation in elderly patients with multiple myeloma: A single-center retrospective analysis.
H. Wiebach, Deniz Gezer, T. Brummendorf, M. Crysandt +1 more
2020Current Research in Translational Medicine5 citations
Semantic Scholar
10-Day Decitabine Versus Intensive Chemotherapy Followed By Transplantation in Fit AML Patients Aged ≥60 Years: Health-Related Quality of Life Outcomes of the Randomized Phase III Trial AML21 of the EORTC Leukemia Group, Gimema, Celg, and Gmds-SG
F. Efficace, G. Huls, M. Kicinski, W. van der Velden +23 more
2022Blood4 citations Open access
Semantic Scholar
Randomized Phase II Study of All-Trans Retinoic Acid and Valproic Acid Added to Decitabine in Newly Diagnosed Elderly AML Patients (DECIDER trial): Predictive Impact of TP53 Status
H. Becker, C. Schmoor, O. Grishina, D. Pfeifer +29 more
2021Blood4 citations
Semantic Scholar
Venetoclax-Azacitidine As Salvage Therapy and Bridge to Allogeneic Cell Transplantation in Relapsed/Refractory AML Compared to Historical Data of the SAL Registry Study
J. Unglaub, R. Schlenk, M. Hanoun, H. Reinhardt +32 more
2021Blood4 citations Open access
Semantic Scholar
Secondary-Type Mutations Do Not Impact the Favorable Outcome of NPM1-Mutated Acute Myeloid Leukemia Patients - Results from a Large Cohort of Intensively Treated Patients
Marius Bill, J. Eckardt, Christian Rausch, K. Metzeler +36 more
2023Blood3 citations
Semantic Scholar
Impaired Overall Survival in Young Patients With Acute Myeloid Leukemia and Variants in Genes Predisposing for Myeloid Malignancies
M. Kirschner, Benjamin Rolles, M. Crysandt, C. Röllig +15 more
2022HemaSphere3 citations Open access
Semantic Scholar
S125: 10-DAY DECITABINE VS. CONVENTIONAL CHEMOTHERAPY (“3 + 7”) FOLLOWED BY ALLOGRAFTING (HSCT) IN AML PATIENTS ≥60 YEARS: A RANDOMIZED PHASE III STUDY OF THE EORTC LEUKEMIA GROUP, GIMEMA, CELG, AND GMDS-SG
M. Lübbert, P. Wijermans, M. Kicinski, S. Chantepie +30 more
2022HemaSphere3 citations Open access
Semantic Scholar
Lower-dosing ponatinib in pre-treated GIST: Results of the POETIG phase II trial.
J. Falkenhorst, R. Hamacher, P. Reichardt, P. Ivanyi +9 more
20203 citations
Semantic Scholar
Spatial profiling of the spleen in mouse and human myelofibrosis reveals complement-driven immune-stromal interactions as a therapeutic target.
B. Dugué, Pia Wanner, Mayra L. Ruiz-Tejada-Segura, Mohamed Saad +35 more
2026Cell Stem Cell2 citations Open access
Semantic Scholar
10-day decitabine versus conventional chemotherapy (“3+7”) followed by allografting in AML patients ≥ 60 years: Long-term follow-up results of the randomized phase III trial AML21 of the EORTC leukemia group, GIMEMA and german MDS Study group
M. Lübbert, P. Wijermans, M. Kicinski, S. Chantepie +33 more
2025Blood2 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

T. Brümmendorf×22
Invite
T. Brümmendorf — researcher profile on SciRah
M. Bornhäuser×17
Invite
M. Bornhäuser — researcher profile on SciRah
C. Müller-Tidow×17
Invite
C. Müller-Tidow — researcher profile on SciRah
C. Röllig×15
Invite
C. Röllig — researcher profile on SciRah

×15

Invite

H. Serve — researcher profile on SciRah

Invite

B. Steffen — researcher profile on SciRah

U. Platzbecker×15

Invite

U. Platzbecker — researcher profile on SciRah

C. Schliemann×14

Invite

C. Schliemann — researcher profile on SciRah

A. Neubauer×13

Invite

A. Neubauer — researcher profile on SciRah

M. Kaufmann×12

Invite

M. Kaufmann — researcher profile on SciRah

K. Schäfer-Eckart×11

Invite

K. Schäfer-Eckart — researcher profile on SciRah

Invite

M. Hänel — researcher profile on SciRah